CD4 and COVID-19: Another limitation of this study was that no linking of the CrAg and COVID-19 results was undertaken to assess co-infection and the possible impact that COVID-19 infection would have played in the reduction of CD4 count and further immunosuppression that would have led to a higher likelihood of contracting Cryptococcal disease.